Cambridge Investment Research Advisors, Inc. Moderna, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 20,880 shares of MRNA stock, worth $708,040. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,880
Previous 22,940
8.98%
Holding current value
$708,040
Previous $954,000
37.95%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding MRNA
# of Institutions
859Shares Held
255MCall Options Held
23.9MPut Options Held
30.2M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.37 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$867 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$846 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$603 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$253 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...